Annotation Detail for NSF

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04962 | Vasopressin-regulated water reabsorption |
Pathway ID | Pathway Name |
---|
| Synaptic Transmission |
Pathway ID | Pathway Name |
---|
P00037 | Ionotropic glutamate receptor pathway |
P05734 | Synaptic vesicle trafficking |
Pathway ID | Pathway Name |
---|
500172 | Trafficking of GluR2-containing AMPA receptors |
Desease Name |
---|
Parkinson's disease |
NEUROLOGICAL |
Desease Name |
---|
Parkinson's disease |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D020106 |
Acrylamide |
Acrylamide binds to and affects the metabolism of NSF protein | affects binding|affects metabolic processing | 17698512
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NSF mRNA | affects expression | 16483693
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NSF mRNA | decreases expression | 20106945
|
C472511 |
dimethylarsinous acid |
dimethylarsinous acid results in decreased expression of NSF mRNA | decreases expression | 16507463
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of NSF mRNA | increases expression | 18035473
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of NSF mRNA | decreases expression | 15860345
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of NSF mRNA | decreases expression | 18927307
|
C010327 |
salinomycin |
salinomycin results in decreased expression of NSF mRNA | decreases expression | 19682730
|
D024505 |
Tocopherols |
Tocopherols results in increased expression of NSF mRNA | increases expression | 17654050
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NSF mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.78 | 19015723 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.73 | 18080171 19368416 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
3.06 | 16253758 18183576 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
3.06 | 19682730 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.15 | 15215559 1977408 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
5.72 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.64 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.62 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 16391804 17454858 17159606 16303861 18259882 18509181 15273666 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.54 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.03 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.75 | 11575062 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.03 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.36 | 12639820 12168785 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.17 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.57 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.15 | 10903974 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
5.39 | 11020651 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
7.67 | 11020651 12507653 15355880 15749267 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.67 | 16467254 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.72 | 17296493 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.43 | 18776723 8314463 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.97 | 16417039 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
7.30 | 19682730 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
7.30 | 17927505 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
4.25 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
4.16 | 15878867 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.25 | 17159606 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.23 | 18259882 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 18481113 19348381 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
4.82 | 12387367 12387366 11264303 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
5.14 | 12164553 12507653 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.56 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.97 | 8761367 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
5.31 | 11510240 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.13 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.17 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
4.57 | 12504091 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.17 | 18629315 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.17 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
4.37 | 11575062 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
2.82 | 19369910 1830565 20107430 18513383 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.36 | 15723263 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.90 | 20210726 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
5.47 | 15864552 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |
Pathway ID |
Pathway Name |
---|
REACT:13685 |
Synaptic Transmission |
KEGG:04962 |
Vasopressin-regulated water reabsorption |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB01902 |
- |
1-Ethyl-Pyrrolidine-2,5-Dione |
|
DB03131 |
- |
Beta-Mercaptoethanol |
|